NiKang Therapeutics
Lorena Donato Galindo has worked in a variety of roles in the Quality Assurance field since 2001. Lorena began their career as a Forensic Chemist at Forensic Science Institute in 2001. In 2003, they moved to Pfizer as a Quality Assurance Analyst. Lorena then worked as a Quality Control Supervisor at Novartis from 2004-2011. From 2011-2016, they were a Quality Assurance Supervisor at Sovereign Pharmaceuticals. Lorena then moved to Monarch PCM as a Quality Assurance Manager from 2016-2019. In 2019, they worked as a Quality Assurance Manager, GMP at Peloton Therapeutics and as an Associate Director, Quality Assurance at Merck. Currently, they are an Sr. Manager Quality Assurance at CARsgen Therapeutics and will be an Associate Director Quality Assurance at NiKang Therapeutics Inc. starting in 2022.
Lorena Donato Galindo has been studying Chemistry at the Universidad de Puerto Rico since their undergraduate studies. Lorena obtained their Bachelor in Science from the University of Puerto Rico, Río Piedras in 2003. Additionally, they have a Certified Quality Auditor (CQA) certification from ASQ obtained in March 2013.
This person is not in any offices
NiKang Therapeutics
NiKang Therapeutics, Inc. is a privately-held biotech company focused on developing novel small molecule oncology drug discovery. Their mission is to discover and develop first-in-class, and/or best-in-class small molecule targeted therapies and immuno-oncology (I-O) drugs to help cure cancers.